ImmunoPrecise Antibodies (OTCMKTS:IPATF) Stock Price Up 0.1%

ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATFGet Free Report)’s share price was up 0.1% during mid-day trading on Wednesday . The stock traded as high as $1.12 and last traded at $1.12. Approximately 31,238 shares changed hands during trading, an increase of 54% from the average daily volume of 20,327 shares. The stock had previously closed at $1.12.

ImmunoPrecise Antibodies Stock Up 0.9 %

The business’s 50 day moving average is $1.29 and its 200 day moving average is $1.50.

About ImmunoPrecise Antibodies

(Get Free Report)

ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.

Read More

Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.